Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.

Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.

Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.

Abstract: The present invention relates to a method for preventing transmission of influenza, wherein said method comprises administering an effective amount of a compound to a patient having an influenza virus infection, herein referred to as “index patient”, wherein the compound has one of the formulae (I) and (II), or its pharmaceutically acceptable salt. The compound to be used in the present invention reduces infectivity of the influenza virus of the index patient, and therefore, reduces the risk of the index patient to trigger an influenza epidemic or an influenza pandemic as compared to a control patient.

Abstract: A seat back (2) has a pad (4) with a side surface covered by a trim cover (5) and a rear surface covered by a back board (6). A back board attachment structure has a folding portion (5a1) with a trim back surface edge portion (5a) folded back to a pad side. A fastener (7a) includes an element (7a2) attached to the folding portion (5a1) to face the pad side. An edge portion (6a) of a folding portion (6a1) of the back board (6), to be the backrest surface side, is folded back to the pad side. A fastener (7b) includes an element (7b2) attached to the folding portion (6a1) to face the pad side. The fasteners (7a and 7b) are engageable in a state with the trim cover provided from the backrest surface side and the back board provided from the back surface side, with respect to the pad.

Abstract: A seat for automobile in which a back board equipped with a base material and a cover for covering that base material is attached to a back side of a seat back, wherein the back board has a first region in which a first member of the base material is set, and a second region that is softer than the first region, and a coupling member for coupling the back board to the seat back is attached to the second region.

Abstract: A seat back (2) has a pad (4) with a side surface covered by a trim cover (5) and a rear surface covered by a back board (6). A back board attachment structure has a folding portion (5a1) with a trim back surface edge portion (5a) folded back to a pad side. A fastener (7a) includes an element (7a2) attached to the folding portion (5a1) to face the pad side. An edge portion (6a) of a folding portion (6a1) of the back board (6), to be the backrest surface side, is folded back to the pad side. A fastener (7b) includes an element (7b2) attached to the folding portion (6a1) to face the pad side. The fasteners (7a and 7b) are engageable in a state with the trim cover provided from the backrest surface side and the back board provided from the back surface side, with respect to the pad.

Abstract: A seat for automobile in which a back board equipped with a base material and a cover for covering that base material is attached to a back side of a seat back, wherein the back board has a first region in which a first member of the base material is set, and a second region that is softer than the first region, and a coupling member for coupling the back board to the seat back is attached to the second region.